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(157 ± 3 vs. 180 ± 8 ml) in 2 of the 7 participants. There 
was a significant positive relationship between the decrease 
in V˙O2max from sea level to high altitude and the change in 
DLCO and lung diffusing capacity for nitric oxide (DLNO) 
from rest to end-exercise at high altitude.
Conclusion These data suggest that recruitment of the pul-
monary capillaries in response to exercise at high altitude is 
limited in most well-acclimatized humans but that any such 
a reserve may be associated with better exercise capacity.
Keywords Lung diffusing capacity · Maximal oxygen 
consumption · Pulmonary artery systolic pressure · Sea 
level
Abbreviations
CPET  Cardiopulmonary exercise test
DLCO  Lung diffusing capacity for carbon monoxide
DLNO  Lung diffusing capacity for nitric oxide
DmCO  Alveolar-capillary membrane conductance
PAP  Pulmonary arterial pressure
PVR  Pulmonary vascular resistance
RER  Respiratory exchange ratio
RPE  Rating of perceived exertion
sPAP  Systolic pulmonary arterial pressure
Vc  Pulmonary capillary blood volume
V˙E  Minute ventilation
V˙O2  Oxygen consumption
V˙CO2  Carbon dioxide production
Introduction
In healthy humans, the elevation in cardiac output and pul-
monary perfusion pressure during exercise cause a marked 
expansion of the highly compliant pulmonary capillary 
Abstract 
Purpose We determined whether well-acclimatized 
humans have a reserve to recruit pulmonary capillaries in 
response to exercise at high altitude.
Methods At sea level, lung diffusing capacity for car-
bon monoxide (DLCO), alveolar-capillary membrane 
conductance (DmCO), and pulmonary capillary blood vol-
ume (Vc) were measured at rest before maximal oxygen 
consumption (V˙O2max) was determined in seven adults. 
Then, DLCO, DmCO and Vc were measured pre- and post-
exhaustive incremental exercise at 5150 m after ~40 days 
of acclimatization.
Results Immediately after exercise at high altitude, 
there was an increase in group mean DmCO (14 ± 10 %, 
P = 0.040) with no pre- to post-exercise change in group 
mean DLCO (46.9 ± 5.8 vs. 50.6 ± 9.6 ml/min/mmHg, 
P = 0.213) or Vc (151 ± 28 vs. 158 ± 37 ml, P = 0.693). 
There was, however, a ~20 % increase in DLCO from 
pre- to post-exercise at high altitude (51.2 ± 0.2 vs. 
61.1 ± 0.2 ml/min/mmHg) with a concomitant increase 
in DmCO (123 ± 2 vs. 156 ± 4 ml/min/mmHg) and Vc 
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network (La Gerche et al. 2010; Lalande et al. 2012; Stokes 
et al. 1981; Tamhane et al. 2001; Taylor et al. 2014). 
Indeed, the increase in lung diffusing capacity for carbon 
monoxide (DLCO) and nitric oxide (DLNO), alveolar-
capillary membrane conductance (DmCO) and pulmonary 
capillary blood volume (Vc) associated with whole body 
exercise is indicative of both recruitment of previously 
closed pulmonary capillaries and distension of the per-
fused pulmonary vessels (Johnson et al. 1960; Pavelescu 
et al. 2013; Stokes et al. 1981; Tamhane et al. 2001). At sea 
level, DLCO, DLNO, DmCO and Vc increase linearly with 
increasing workload with no evidence of a plateau in these 
variables throughout exhaustive exercise (Hsia et al. 1995; 
Johnson et al. 1960; Tamhane et al. 2001; Taylor et al. 
2014; Zavorsky et al. 2004). This suggests that recruitment 
and distension of the pulmonary capillaries do not become 
limited even during heavy- to maximal exercise in healthy 
humans. That the expansion of the pulmonary capillar-
ies appears not to reach a maximum during exercise likely 
serves to allow an increase in the alveolar-capillary surface 
area for effective gas exchange whilst minimizing the exer-
cise-induced increase in pulmonary arterial pressure (PAP), 
pulmonary vascular resistance (PVR) and right ventricular 
afterload, all of which have been associated with greater 
exercise aerobic capacity at sea level (La Gerche et al. 
2010; Lalande et al. 2012; Pavelescu et al. 2013).
Exposure to airway hypoxia and/or high altitude also 
elicits pulmonary capillary recruitment due to an increase 
in pulmonary perfusion pressure secondary to hypoxic 
pulmonary vasoconstriction (Brimioulle et al. 1996; de 
Bisschop et al. 2012; Taylor et al. 2011). At rest, it is prob-
able that the increase in alveolar-capillary surface area 
associated with recruitment of the pulmonary capillaries 
improves ventilation–perfusion matching and thus bet-
ter preserves systemic oxygen levels in humans at high 
altitude. However, in the setting of ongoing hypoxic pul-
monary vasoconstriction, it is possible that the associated 
recruitment and distension of the pulmonary capillar-
ies may limit or encroach upon the reserve for expansion 
of the pulmonary vasculature in response to whole body 
exercise at high altitude. That is, we considered it possible 
that exposure to hypobaric hypoxia may elicit maximal, or 
near maximal, recruitment and distension of the pulmonary 
vasculature such that no reserve remains for further expan-
sion of the pulmonary capillaries in response to exercise at 
high altitude. Any such limitation in pulmonary capillary 
recruitment and distension during exercise at high altitude 
would likely be associated with an inability to adequately 
increase gas exchange surface area along with an excessive 
rise in PAP and PVR relative to the metabolic demand of 
exercise, which in turn would be expected to significantly 
impair exercise capacity (La Gerche et al. 2010; Lalande 
et al. 2012; Naeije et al. 2010; Pavelescu et al. 2013).
It has been shown previously that a large pulmonary 
vascular reserve, defined as low pulmonary vascular resist-
ance in combination with elevated lung diffusing capacity, 
is associated with better aerobic exercise capacity at high 
altitude (Pavelescu et al. 2013). However, we are unaware 
of any previous study that has assessed whether well-accli-
matized healthy humans maintain a reserve to recruit and 
distend the pulmonary vasculature in response to exercise 
at high altitude. Accordingly, the aim of the present study 
was to determine (1) whether well-acclimatized humans 
have a reserve to further recruit and distend the pulmonary 
capillaries in response to exercise at high altitude, and (2) 
whether such reserve is related to aerobic exercise capacity 
at high altitude. Experimentally, we reasoned that individu-
als with a reserve to recruit and/or distend the pulmonary 
capillaries in response to exercise at high altitude would 
exhibit a large pre- to post-exercise increase in DLCO, 
DLNO, DmCO and Vc. Moreover, we expected that individ-
uals in whom a pulmonary vascular reserve was evidenced 
at high altitude would also exhibit better maintenance of 
exercise capacity (i.e., a higher V˙O2max) at high altitude 




Seven healthy nonsmoking North American adults (5 
male, 2 female) with no history of cardiorespiratory or 
metabolic disease participated in the study (mean ± SD; 
age = 35 ± 10 years, stature = 177 ± 11 cm, body 
mass = 74.6 ± 12.0 kg). The subjects were physi-
cally active (≥30 min physical activity/day, ≥5 days/
week; self-reported) and had normal forced vital capacity 
(FVC = 120 ± 11 % of predicted), forced expiratory vol-
ume in 1 s (FEV1 = 108 ± 7 % of predicted), FEV1/FVC 
ratio (96 ± 6 % of predicted) and maximal mid-expiratory 
flow (MMEF = 114 ± 10 % of predicted) at sea level. 
Each participant gave written informed consent after being 
provided a detailed description of the study requirements. 
The experimental procedures were approved by the Mayo 
Clinic Institutional Review Board and were performed in 
accordance with the ethical standards of the Declaration of 
Helsinki. All study participants were prohibited from pro-
phylactic administration of any medication to aid altitude 
acclimatization (e.g., sildenafil, acetazolamide). Moreo-
ver, no subject required emergent pharmaceutical treat-
ment (e.g., dexamethasone) for high altitude illness. During 
the trek to high altitude, two subjects were given an acute 
course (2 days) of a broad spectrum antibiotic for the treat-
ment of a suspected gastro-intestinal infection.
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Experimental procedures
At sea level (Rochester, MN, USA; elevation 401 m), pul-
monary function was assessed using a spirometer according 
to standard procedures (Miller et al. 2005) before pulmo-
nary artery systolic pressure (sPAP) (via echocardiography) 
and lung diffusing capacity for carbon monoxide and nitric 
oxide (DLCO and DLNO) were measured at rest (Fig. 1). 
Next, the cardiorespiratory responses to maximal incre-
mental treadmill exercise were assessed in each participant 
as described previously (Bruce et al. 1963) (Fig. 1). Within 
2 weeks of completion of the sea level measurements, each 
subject traveled to Kathmandu, Nepal (elevation 1400 m) 
before being transported by airplane to Lukla, Nepal (ele-
vation 2860 m). From Lukla, the participants completed an 
8–10 day hike at progressively increasing altitudes to reach 
Mount Everest Base Camp. After a further ~30 days of 
acclimatization to high altitude (group mean maximum ele-
vation reached 6385 ± 917 m, range 5150–7200 m), sPAP 
was measured at rest before DLCO, DLNO, alveolar-capil-
lary membrane conductance (DmCO) and pulmonary capil-
lary blood volume (Vc) were assessed before and immedi-
ately after incremental step exercise performed to volitional 
exhaustion at Mount Everest Base Camp (Fig. 1).
Pulmonary artery pressure
sPAP was estimated from the peak velocity of tricuspid 
regurgitation (TR) using a modified Bernoulli equation as 
described previously (Taylor et al. 2011; Yock and Popp 
1984). With the participants in the left lateral supine posi-
tion, the TR jet was located using 2D-color Doppler echo-
cardiography (SonoSite Edge, FUJIFILM SonoSite Inc., 
Bothell, WA). To determine the maximal velocity of the TR 
jet, the continuous wave sampler was positioned within and 
parallel to the regurgitation jet and sPAP was computed as 
4TR2 added to an assumed right atrial pressure of 5 mmHg.
Lung diffusing capacity
With subjects in the sitting position, DLCO and DLNO 
were assessed by simultaneously measuring the disappear-
ance of CO and NO via a rapid single breath technique 
using an automated device for performing gas calibrations, 
extemporaneous mixing of gases and calculations (Hyp’air 
Compact, Medisoft, Dinant, Belgium) (de Bisschop et al. 
2012; Pavelescu et al. 2013). For each single breath 
maneuver, the participants were instructed to breathe nor-
mally on environmental air for 4–5 breaths before exhal-
ing slowly and completely down to residual volume (RV). 
Once at RV, the participants were switched to an inspira-
tory reservoir filled with 2600 ppm CO, 40 ppm NO, 
8 % He, 21 % O2 and N2 balance, and told to inspire rap-
idly and fully to total lung capacity before holding their 
breath for 4 s. After the breath hold, the participants then 
exhaled steadily and swiftly back to RV. The first 0.9 L of 
the expired gas was discarded to ensure dead-space wash 
out with the next 0.9 L of the expirate collected for subse-
quent analysis. The single breath maneuver was performed 
in duplicate before (<10 min) and after maximal exer-
cise at high altitude. The first post-exercise single breath 
maneuver was performed within 20 s of end-exercise with 
the second performed 4 mins later, according to current 
guidelines (Macintyre et al. 2005). Importantly, pilot data 
from our laboratory have suggested that transient exposure 
to 40 ppm NO during the assessment of lung diffusing 
Fig. 1  Schematic depiction of the experimental procedures used in 
this study. At sea level, pulmonary function (stripped up arrow), sys-
tolic pulmonary arterial pressure (sPAP) (solid up arrow) and lung 
diffusing capacity for carbon monoxide and nitric oxide (DLCO and 
DLNO), alveolar-capillary membrane conductance (DmCO) and pul-
monary capillary blood volume (Vc) (open up arrow) we measured at 
rest before subject performed a maximal incremental cardiopulmo-
nary exercise test (CPET) on a motorized treadmill. Within 2 weeks 
of baseline sea level testing, each subject traveled to Kathmandu, 
Nepal (elevation 1400 m) before being transported by airplane to 
Lukla, Nepal (elevation 2860 m). From Lukla, the participants com-
pleted an 8–10 day hike at progressively increasing altitudes to reach 
Mount Everest Base Camp. After a further ~30 days of acclimati-
zation to high altitude, sPAP was measured at rest (solid up arrow) 
before DLCO, DLNO, DmCO and Vc were assessed before and imme-
diately after a CPET to volitional exhaustion at Mount Everest Base 
Camp. Due to the logistical constraints of performing exercise at high 
altitude, CPET at Base camp was conducted by having subjects per-
form 1 min of step exercise at a rate of 60 steps per min, before the 
work rate was increased by 30 steps per min every 1 min until they 
were unable to maintain the required step rate and/or reached voli-
tional exhaustion; the step height was set at 20 cm and the partici-
pants maintained the required step rate by following a metronome
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capacity has no discernible effect on systolic pulmonary 
artery pressure in humans exposed to normobaric hypoxia 
(FIO2 12.5 %) for ~17 h (sPAP: 32.7 ± 5.9 pre-DLCO/
DLNO assessment vs. 31.6 ± 6.4 mmHg post-DLCO/
DLNO assessment, n = 5). Thus, it appears that the tran-
sient administration NO gas associated with our assess-
ment of DLNO and DLNO does not alter pulmonary vas-
cular tone such that our measures of DLCO, DmCO and Vc 
would be affected.
Following the assessment of lung diffusing capacity, 
DmCO and Vc were computed as described previously (de 
Bisschop et al. 2012; Glenet et al. 2007; Pavelescu et al. 
2013). Based on the molecular weight and solubility of CO 
and NO, the coefficient relating DLNO to DmCO was set at 
1.97 (Aguilaniu et al. 2008) such that DmCO was calculated 
as the measured DLNO/1.97. Then, to solve the Roughton 
and Forster equation (Roughton and Forster 1957), 1/⊖CO 
was calculated using an equation proposed by Forster 
expressing the blood conductance of CO (i.e. ⊖CO) as a 
function of capillary PO2 (Forster 1987):
where PcapO2 is the capillary pressure of O2, estimated as 
alveolar PO2 − V˙O2/(DLCO × 1.23) with partial pressures 
in mmHg, V˙O2 in ml/min, and DLCO in ml/min/mmHg. 
Based on the measured barometric pressure (~400 mmHg) 
and the expired fraction of O2, the calculated alveolar PO2 
at Everest Base Camp ranged from 55 to 58 mmHg. V˙O2 
was calculated using the mass balance of O2 between inspi-
ration and expiration during the single breath maneuver 
and DLCO × 1.23 was used as a surrogate for DLO2 (For-
ster, 1987). Using this equation, PcapO2 was calculated as 
120 ± 7 mmHg and 53 ± 5 mmHg at sea level and Everest 
Base Camp, respectively; these values are similar to those 
recently reported under similar conditions (de Bisschop 
et al. 2012). Venous blood was sampled for hemoglobin 
(Hb) concentration and Vc was corrected accordingly 
for standard concentrations of Hb in men (14.6 g/dl) and 
women (13.4 g/dl) (Macintyre et al., 2005) as measured 
Vc × (standard Hb concentration/measured Hb concentra-
tion). To allow comparison between DLCO measured at 
sea level and high altitude, DLCO at Everest Base Camp 
was recalculated using the DmCO and Vc values computed 
at high altitude and the sea level (i.e., normoxic) ⊖CO as 
follows (Pavelescu et al. 2013):
where, DmCOALT and VcALT are the alveolar-capillary mem-
brane conductance and pulmonary capillary blood volume, 
respectively, calculated at Everest Base Camp using the 
hypoxic ⊖CO and ⊖COSL is the ⊖CO at sea level (i.e., the 
normoxic ⊖CO).
1/⊖CO = 1.3+ 0.0041× PcapO2
1/DLCOALT = 1/DmCOALT + 1/⊖COSL ·VcALT
Cardiopulmonary exercise test at high altitude
Following 2 min of quiet rest, the participants performed 
1 min of step exercise at a rate of 60 steps per min, before 
the work rate was increased by 30 steps per min every 1 min 
until they were unable to maintain the required step rate 
and/or reached volitional exhaustion. The step height was 
set at 20 cm and the participants maintained the required 
step rate by following a metronome. Ventilatory and pul-
monary gas exchange indices, including minute ventila-
tion (V˙E ), oxygen consumption (V˙O2) and carbon dioxide 
production (V˙CO2), were measured breath-by-breath using 
a system with integrated pneumotachometer (VO2000 Meta-
bolic Measurement System, MGC Diagnostics, St. Paul, 
MN) and averaged over the last 20 s of each minute dur-
ing exercise. Similarly, heart rate (HR) and estimated arte-
rial oxygen saturation (SaO2) were assessed beat-by-beat 
during exercise using a pulse oximeter (NONIN PureSAT 
Model 3150 Oximeter, NONIN Medical Inc., Plymouth, 
MN) with finger sensor, and averaged over the last 20 s 
of each minute during exercise. From these parameters, 
derived variables including V˙E/V˙CO2 ratio, respiratory 
exchange ratio (RER) and oxygen pulse (V˙O2/HR) were 
calculated and averaged as described above. Ratings of per-
ceived exertion (dyspnea and whole body) were obtained at 
rest, at 1 min of exercise, and every 1 min thereafter using 
Borg’s 6–20 scale.
Statistical analyses
The within-subject coefficient of variation (CV) for DLCO 
and DLNO was used to estimate the sample size required 
to detect meaningful changes in DLCO and DLNO from 
before to after the cardiopulmonary exercise test at high 
altitude (approximately double the CV) given a statisti-
cal power of 0.8 and an alpha level of 0.05 (Hopkins et al. 
1999). Based on a CV of 4.78 % for DLCO and 4.94 % for 
DLNO (calculated in our laboratory), respectively, a sample 
size of 7 allowed us to detect a 7.5 % change in DLCO and 
an 8.0 % change in DLNO. The CV was determined using 
the method error of the measurement. Repeated measures 
ANOVA was used to compare absolute measures of lung 
diffusing capacity and related variables (DLCO, DLNO, 
DmCO and Vc) across time (sea level at rest vs. altitude at 
rest before exercise vs. altitude immediately after exercise). 
When significant main effects were shown, planned pair-
wise comparisons were made with the Bonferroni method. 
Paired samples t test was used to compare the cardiorespi-
ratory (e.g., V˙E, V˙O2, HR, SaO2 and derived variables) and 
perceptual (RPE dyspnea and RPE whole body) responses 
to the final minute of maximal incremental exercise at sea 
level vs. at high altitude. Paired samples t test was also 
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used to compare resting sPAP at sea level vs. at high alti-
tude. Pearson’s product-moment correlation coefficient (r) 
was computed to assess (1) the relationship between the 
absolute change (∆) in DLCO and DLNO from before to 
after exercise at high altitude and the absolute change (∆) 
in V˙O2max from sea level to high altitude, and (2) the rela-
tionship between pulmonary artery systolic pressure and 
V˙O2max measured at sea level and at high altitude. The 
acceptable type I error was set at P < 0.05. Where appro-
priate, data are expressed as group mean ± SD. Statistical 
analyses were performed using SPSS version 12.0 for Win-
dows (SPSS, Chicago, IL).
Results
General effects of high altitude
Overall, the participants acclimatized well to high alti-
tude and reported only mild, transient degrees of headache 
and fatigue/weakness during the 5 days preceding experi-
mentation at Everest Base Camp. On the morning of the 
experimentation day at Everest Base Camp, group mean 
Lake Louise score (2 ± 1) was not positive for the pres-
ence of acute mountain sickness. From sea level to the 
day of experimentation at Everest Base Camp, there was a 
decrease in resting SaO2 (97 ± 1 vs. 84 ± 5 %, P < 0.001) 
and an increase in resting HR (69 ± 14 vs. 83 ± 9 beats/
min, P = 0.035), hemoglobin concentration (15.4 ± 1.4 
vs. 17.8 ± 1.4 g/dL, P = 0.007) and sPAP (19.5 ± 4.5 vs. 
29.2 ± 3.2 mmHg, P = 0.002).
Lung diffusing capacity
Lung diffusing capacity at rest: sea level vs. high altitude
Resting measures of DLCO, DmCO and Vc at sea level and 
on the day of experimentation at Everest Base Camp are 
shown in Table 1. From sea level to high altitude, there was 
a significant increase in group mean DLCO (10 ± 4 %, 
P < 0.001) and DmCO (18 ± 11 %, P = 0.007). By con-
trast, group mean Vc at rest was not different at high alti-
tude compared to sea level (151 ± 28 vs. 139 ± 34 ml, 
P = 0.667) (Table 1). There was no change in resting 
DLNO/DLCO and resting DmCO/Vc from sea level to high 
altitude (Table 1).
Effect of exercise at high altitude on lung diffusing capacity
Individual participant and group mean changes in DLCO, 
DmCO and Vc from before to after exercise at high alti-
tude are shown in Fig. 2. Immediately after exercise, 
there was a small but significant increase in group mean 
DmCO (14 ± 10 %, P = 0.040) with no pre- to post-
exercise change in group mean DLCO (46.9 ± 5.8 vs. 
50.6 ± 9.6 ml/min/mmHg, P = 0.213) or Vc (151 ± 28 
vs. 158 ± 37 ml, P = 0.693) (Fig. 2). There was, how-
ever, a ~20 % increase in DLCO from before to after exer-
cise at high altitude (51.2 ± 0.2 vs. 61.1 ± 0.2 ml/min/
mmHg) with a concomitant increase in DmCO (123 ± 2 vs. 
156 ± 4 ml/min/mmHg) and Vc (157 ± 3 vs. 180 ± 8 ml) 
in 2 of the 7 participants (denoted by the open circle and 
open diamond in Fig. 1). In the remaining 5 subjects, there 
was either a minimal increase (subjects denoted by the 
star and the open square in Fig. 1) or no change in DLCO, 
DmCO and Vc from before to after exercise at high altitude 
(Fig. 1).
Cardiorespiratory responses to exercise: sea level vs. 
high altitude
The cardiorespiratory and perceptual responses to the final 
minute of maximal incremental exercise at sea level and 
at high altitude are shown in Table 2. Compared to sea 
level, altitude exposure was associated with a decrease in 
peak V˙O2 (−20 ± 7 %, P = 0.002), peak V˙E (−29 ± 9 %, 
P = 0.001), peak HR (−19 ± 4 %, P < 0.001), O2pulse 
(−8 ± 6 %, P = 0.014) and SaO2 (−20 ± 5 %, P < 0.001) 
at end-exercise. RER, V˙E/V˙CO2, O2pulse and perceptions 
of dyspnea and whole body discomfort were not different 
at end-exercise at high altitude compared to at sea level 
(Table 2).
Correlations
There was a significant positive relationship between the 
magnitude of the decrease in V˙O2max from sea level to 
high altitude and the change in DLCO and DLNO from 
rest to end-exercise at high altitude (r2 = 0.698, P = 0.019; 
Table 1  Resting lung diffusion variables at sea level and after accli-
mation to high altitude
Values are group mean ± SD for 7 subjects (2 female). Measures at 
high altitude (5150 m) made after ~40 days of high altitude acclima-
tization
DLCO lung diffusing capacity for carbon monoxide, DLNO lung dif-
fusing capacity for nitric oxide, DmCO alveolar-capillary membrane 
conductance, Vc pulmonary capillary blood volume
Sea level High altitude P value
DLCO, ml/min/mmHg 42.8 ± 6.2 46.9 ± 5.8 <0.001
DLNO, ml/min/mmHg 178 ± 26 208 ± 26 0.007
DLNO/DLCO 4.19 ± 0.56 4.46 ± 0.43 0.594
DmCO, ml/min/mmHg 90 ± 13 106 ± 13 0.007
Vc, ml 139 ± 34 151 ± 28 0.667
DmCO/Vc 0.69 ± 0.18 0.71 ± 0.13 0.731
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and r2 = 0.743, P = 0.013, respectively) (Fig. 3). In addi-
tion, there was a significant negative relationship between 
resting sPAP and V˙O2max at high altitude (r2 = − 0.517, 
P = 0.041) but not at sea level (r2 = 0.141, P = 0.464).
Discussion
Main findings
The main finding of the present study was that exhaustive 
incremental exercise at high altitude caused a small but sig-
nificant increase in group mean lung diffusing capacity for 
nitric oxide (DLNO) and alveolar-capillary membrane con-
ductance (DmCO), but no change in lung diffusing capac-
ity for carbon monoxide (DLCO) or pulmonary capillary 
blood volume (Vc). There was, however, a large (~20 %) 
increase in DLCO from before to immediately after exer-
cise at high altitude with a concomitant increase DmCO and 
Vc in two of the seven subjects studied, with minimal or no 
increase in these parameters in the remaining participants. 
A large pre- to post-exercise increase in DLCO and its 
related variables was considered to be ≥15 % (Horita et al. 
2015). Interestingly, there was a significant positive rela-
tionship between the magnitude of the decrease in V˙O2max 
from sea level to high altitude and the change in DLCO and 
DLNO from rest to end-exercise at high altitude. In com-
bination, these findings suggest that (1) recruitment of the 
pulmonary capillaries in response to exercise at high alti-
tude is limited in most well-acclimatized humans, and (2) 
there is perhaps a very small number of individuals who 
do maintain a reserve to recruit and distend the pulmonary 
capillaries in response to exercise in this environment, and 
that the presence of such a reserve is associated with better 
maintained aerobic exercise capacity at high altitude.
Role of pulmonary capillary reserve in the 
determination of exercise capacity at high altitude
It is well known that exercise capacity is substantially 
limited at high altitude, even in well-acclimatized healthy 
humans (Calbet et al. 2003; Fulco et al. 1998). While the 
mechanisms that underpin the decline in exercise capac-
ity at high altitude are multifactorial, it has been reported 
that a persistent reduction in maximal cardiac output along 
with a preferential redistribution of blood flow and thus 
Fig. 2  Individual subject (dashed lines) and group mean (solid 
circles) changes in lung diffusing capacity for carbon monoxide 
(DLCO, Panel A), lung diffusing capacity for nitric oxide (DLNO, 
Panel B), alveolar-capillary membrane conductance (DmCO, Panel 
C) and pulmonary capillary blood volume (Vc, Panel D) from pre- to 
post-exercise at high altitude. The female subjects are represented 
as the open square and the open up triangle. *P < 0.05, group mean 
value significantly different after vs. before exercise
433Eur J Appl Physiol (2016) 116:427–437 
1 3
oxygen delivery to non-exercising tissues play a criti-
cal role in the failure to recover V˙O2max in acclimatized 
humans, despite normalization of arterial oxygen content 
(Calbet et al. 2003; Fulco et al. 1998; Wagner 2000). It is 
becoming increasingly clear, however, that exercise capac-
ity at high altitude is also related to pulmonary vascular 
function and alterations in pulmonary vascular pressure 
and resistance (de Bisschop et al. 2012; Naeije et al. 2010; 
Pavelescu et al. 2013). In a recent retrospective review 
of data collected during four separate high altitude expe-
ditions, Pavelescu et al. (2013) found that V˙O2max was 
negatively related to resting pulmonary artery pressure 
but positively related to resting lung diffusing capacity for 
nitric oxide at high altitude as well as at sea level. More-
over, the authors reported that the high altitude related 
decrease in V˙O2max was inversely related to the increase 
in resting PVR observed at high altitude (Pavelescu et al. 
2013). In addition, a number of previous studies have 
demonstrated that pharmacologic reduction of pulmonary 
artery pressure and pulmonary vascular resistance second-
ary to dilation of the pulmonary vascular resistance ves-
sels is associated with an improvement in exercise capac-
ity and an increase in the membrane component of lung 
diffusion in humans exposed to hypoxia and/or high alti-
tude (de Bisschop et al. 2012; Faoro et al. 2009; Faoro 
et al. 2007; Ghofrani et al. 2004; Naeije et al. 2010). For 
example, Naeije et al. (2010) reported that administration 
of sitaxsentan, a selective endothelin-A receptor blocker, 
decreased PVR with a concomitant partial restoration in 
V˙O2max in subjects exposed to both acute normobaric 
hypoxia and chronic hypobaric hypoxia. Taken together, 
the aforementioned findings imply that the presence of a 
less distensible pulmonary vascular network in combina-
tion with the development of hypoxia-mediated pulmonary 
hypertension contribute substantially to the limitation in 
aerobic exercise capacity in healthy humans at high alti-
tude. Although the mechanisms by which elevated pulmo-
nary vascular pressures and resistance facilitate a persis-
tent reduction in V˙O2max in this setting are yet to be fully 
elucidated, it is likely that the increase in PAP and PVR, 
and the consequent increase in right ventricular after-
load, act to limit right ventricular outflow and pulmonary 
Table 2  Responses to the final minute of the exhaustive cardiopul-
monary exercise test (CPET) at sea level and after acclimation to high 
altitude
Values are group mean ± SD for 7 subjects (2 female). Values in 
parentheses represent percent of sea level values. Measures at high 
altitude (5150 m) made after ~ 40 days of high altitude acclimation
VO2 oxygen consumption, VE minute ventilation, RER respiratory 
exchange ratio, HR heart rate, O2 pulse oxygen pulse (oxygen con-
sumption/HR), SaO2 arterial oxygen saturation, RPE rating of per-
ceived exertion
Sea level High altitude P value
VO2, ml/kg/min 48.7 ± 5.2 39.0 ± 2.9  
(80 ± 5)
0.002
VE, l/min 135 ± 19 95 ± 24  
(70 ± 5)
0.001
RER 1.18 ± 0.08 1.12 ± 0.06  
(96 ± 3)
0.128
VE/VCO2 32.9 ± 2.2 35.3 ± 2.2 0.408
HR, beats/min 183 ± 19 148 ± 16  
(81 ± 4)
<0.001
O2pulse, ml/beat 19.3 ± 3.7 18.0 ± 4.5 0.014
SaO2,  % 96 ± 1 77 ± 5 <0.001
RPE dyspnea, CR10 9.7 ± 0.7 9.5 ± 1.0  
(98 ± 2)
0.392
RPE whole body, Borg 6-20 18.8 ± 0.9 18.3 ± 1.0  
(97 ± 4)
0.415
Fig. 3  Scatter plots showing relationships between the individual 
subject maximal oxygen consumption (V˙O2max) at high altitude and 
the pre- to post-exercise change in lung diffusing capacity for carbon 
monoxide (DLCO, Panel A) and lung diffusing capacity for nitric 
oxide (DLNO, Panel B) at high altitude
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vascular perfusion with a subsequent under-perfusion of 
well-ventilated alveoli (V/Q˙ mismatching) and a reduction 
in O2 delivery to the working muscles.
It is well known that exposure to airway hypoxia and/
or high altitude elicits recruitment of the pulmonary cap-
illaries due to an increase pulmonary perfusion pressure 
secondary to hypoxic pulmonary vasoconstriction (Bri-
mioulle et al. 1996; de Bisschop et al. 2012; Taylor et al. 
2011). In the present study, we theorized that this under-
lying hypoxia-mediated recruitment and distension of 
the pulmonary capillaries may limit or encroach upon an 
individual’s reserve to further expand the pulmonary capil-
lary network in response to exercise at high altitude, and 
that any such limitation would be a source of diminished 
exercise capacity in this environment via an impairment in 
the increase in alveolar-capillary surface area for effective 
gas exchange and a heightened exercise-induced increase 
in PAP and PVR. We found that ~40 days of exposure to 
high altitude was associated with substantial hypoxic pul-
monary vasoconstriction and recruitment of the pulmonary 
capillaries, as evidenced by a significant increase in sPAP 
(~56 %), DLCO (~10 %) and DmCO (~18 %) relative to 
sea level values. In addition, we found that only 2 of the 
7 well acclimated healthy humans studied maintained a 
reserve to further recruit and distend the pulmonary capil-
laries in response to exercise at high altitude, as evidenced 
by a substantial pre- to immediately post-exercise increase 
in DLCO (~20 %), DmCO (~28 %) and Vc (~15 %) (Fig. 1). 
Interestingly, there was a significant positive relationship 
between the magnitude of the decrease in V˙O2max from 
sea level to high altitude and the change in DLCO and 
DLNO from rest to end-exercise at high altitude (Fig. 3). In 
combination, these data suggest that encroachment upon or 
lack of a reserve to expand the pulmonary vasculature dur-
ing exercise may be a significant source of exercise limita-
tion at high altitude even in well-acclimatized individuals, 
perhaps via a limitation in effective surface area for pulmo-
nary gas exchange and/or an excessive rise in pulmonary 
vascular pressures and RV afterload.
Why do some but not all humans maintain a pulmonary 
capillary reserve at high altitude?
The underlying physiological reason(s) that underpin why 
pulmonary capillary expansion is largely limited during 
exercise in most well-acclimatized humans, with only a 
small number of individuals (2 of 7 in the present study) 
exhibiting evidence for a reserve to recruit and distend 
the pulmonary capillaries in response to exercise in this 
environment, are unknown and cannot be elucidated from 
the findings of the present study. However, while some-
what speculative, one possible explanation is that lung 
size is related to the cross-sectional area of the pulmonary 
vasculature. That is, individuals with larger lungs likely 
also have a larger pulmonary capillary network and, there-
fore, are able to maintain a reserve to recruit and/or dis-
tend the pulmonary capillaries in response to exercise at 
high altitude in spite of the underlying pulmonary vascular 
recruitment associated with hypoxic pulmonary vasocon-
striction. In support of this postulation, the two individu-
als who were able to markedly increase DLCO, DmCO and 
Vc during exercise at high altitude in the present study both 
had a FVC (6.3 L and 6.2 L) that was greater than the group 
mean (5.5 L including females, 5.8 L excluding females). 
A second potential explanation relates to the highly vari-
able degree of pulmonary vasoreactivity in response to 
hypoxia commonly observed across individuals. Likely 
contributors to this variation are alterations in iron status, 
chemosensitivity, estrogen and polymorphisms in several 
hypoxia sensitive genes, including the serotonin transporter 
(5-HTT) gene (Austin et al. 2009; Olson et al. 2007; Smith 
et al. 2008). Theoretically, an abnormally large or excessive 
rise in pulmonary vascular pressure in response to hypoxic 
exposure may also be associated with a larger degree of 
pulmonary vascular recruitment on exposure to high alti-
tude, thus limiting the reserve for further expansion of the 
pulmonary vasculature in response to exercise. Presently, 
while we do not have any evidence that directly relates 
pulmonary vascular pressures to exercise-induced altera-
tions in pulmonary capillary recruitment (i.e., changes in 
lung diffusing capacity) at high altitude, we did find that 
V˙O2max was related to baseline pulmonary arterial pres-
sure as well as the change in lung diffusion variables dur-
ing exercise at high altitude.
Technical considerations
Correlation data: sample size
One potential limitation of the present study is that the 
somewhat small cohort of subjects studied likely increased 
the potential of a type I error. Specifically, it is plausible 
that the clustering of our data into two relatively distinct 
groups could be, at least in part, contributing to the sig-
nificant linear relationship we have demonstrated between 
the change in V˙O2max from sea level to high altitude and 
the change in DLCO and DLNO in response to exercise 
at high altitude (see Fig. 3). Despite this concern, the pre-
sent findings are remarkably similar to several other recent 
observations. For example, de Bisschop et al. (de Bisschop 
et al. 2012) demonstrated a significant positive relation-
ship between V˙O2max and resting measures of DLCO and 
DLNO, at both sea level and high altitude, in a cohort of 
22 healthy adults. Similarly, in a review of data from 64 
healthy subjects across four different medical expedi-
tions to high altitude, Pavelescu et al. (2013) reported 
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that V˙O2max was positively related to resting measures of 
DLCO and DLNO, and negatively related to mean pulmo-
nary arterial pressure, again at sea level and at high altitude. 
Somewhat in agreement with the aforementioned findings, 
in the present study we found a significant positive relation-
ship between the magnitude of change in V˙O2max from sea 
level to high altitude and the change in DLCO and DLNO 
from before to after exercise at high altitude (see Fig. 3). 
Accordingly, while we concede that the small sample size 
used in this investigation may have increased the likelihood 
of a type I error, we believe that the striking similarities 
between the present findings and the findings reported by 
others who studied larger subject cohorts provides substan-
tial support to our data. Thus, we are confident in our con-
clusion that the presence of reserve to recruit and distend 
the pulmonary capillaries in response to exercise at high 
altitude is associated with better maintained aerobic exer-
cise capacity in this environment.
Specific conductance for NO
Previously, the blood conductance for nitric oxide (⊖NO) 
has been assumed to be either infinite (de Bisschop et al. 
2012; Pavelescu et al. 2013) or finite (Martinot et al. 2013) 
with a value of 4.5 ml/min/mmHg calculated in vivo (Bor-
land et al. 2010). However, although the presence of a 
defined ⊖NO value is an intriguing issue, its use in the cal-
culation of DmCO and Vc remains debated and somewhat 
controversial. Indeed, while it has been estimated that 
37 % of the resistance to NO uptake lies in the 1/⊖NO·Vc 
component (Borland et al. 2010, 2014), it has been argued 
that application of this figure in the whole body human 
must be treated with caution as its calculation involved 
exchange transfusion in dogs, substituting bovine Hb-
glutamer 200 for whole blood (Hughes and van der Lee 
2013). Additionally, it has also been estimated that DLNO 
would not need to be adjusted unless the hemoglobin con-
centration is <8 g/dl (Borland et al. 2010). Thus, it can be 
postulated that if the overall binding or mass transfer of 
NO to hemoglobin is not affected by a substantial lower-
ing of Hb concentration (until lower than 8 g/dl), then the 
resistance proposed to be provided by the red blood cell 
to NO (i.e. ⊖NO) would not have any major physiological 
effect on the measurement of alveolar-capillary membrane 
conductance. Accordingly, there is currently no consensus 
on the application of the assumption of a finite value for 
⊖NO in the calculation of DmCO and Vc in humans. Fur-
thermore, application of a finite ⊖NO of 4.5 ml/min/mmHg 
to the data presented in this study resulted in group mean 
DmCO values of 143 ± 35, 218 ± 51 and 286 ± 104 ml/
min/mmHg at sea level, high altitude pre-exercise and high 
altitude post-exercise, respectively. These DmCO values 
appear excessively large and do not compare favorably to 
values previously reported in whole body humans (e.g., de 
Bisschop et al. 2012). As such, in the present manuscript 
we felt that it was most correct and prudent to calculate 
our DmCO and Vc based on the assumption that ⊖NO is 
infinite.
Exercise modality and potential recovery of lung diffusing 
capacity after exercise at high altitude
A potential concern is that the step-based cardiopulmo-
nary exercise test at high altitude did not elicit a sufficient 
metabolic demand to facilitate pulmonary vascular recruit-
ment, if indeed a reserve for such recruitment remained. 
However, at end-exercise at high altitude V˙O2, V˙E and HR 
reached 80 ± 5, 70 ± 5 and 81 ± 4 % of sea level maxi-
mum (Table 2); these values are very much in agreement 
with the typically reported reduction in exercise capacity 
and percent attainable of sea level values (e.g., de Biss-
chop et al. 2012; Pavelescu et al. 2013). In addition, group 
mean RPE dyspnoea and RPE whole body discomfort 
were remarkably similar at end-exercise at high altitude 
compared to at sea level (Table 2). Based on the aforemen-
tioned considerations, we believe that the stress induced 
by our step exercise protocol at high altitude was appropri-
ate and sufficient enough to serve as a stimulus for addi-
tional pulmonary vascular recruitment, if such a reserve for 
recruitment remained.
An additional concern is that there may have been some 
recovery of any exercise-induced pulmonary vascular 
recruitment and distension during the time between exercise 
termination and our post-exercise measures of lung diffus-
ing capacity at high altitude. Any such recovery may have 
allowed DLCO, DLNO, DmCO and Vc to return towards 
pre-exercise values prior to our post-exercise assessment of 
lung diffusing capacity, potentially causing us to underes-
timate or even miss any exercise-induced expansion of the 
pulmonary vascular bed at high altitude. Despite this con-
cern, in the present study the first post-exercise single breath 
assessment of lung diffusing capacity was performed imme-
diately after exercise termination (within 20 s) with the sec-
ond performed 4 mins later, according to current guidelines 
(Macintyre et al. 2005). Importantly, group mean DLCO 
taken from each single breath measurement was 51.3 ± 9.8 
vs. 49.8 ± 10.1 ml/min/mmHg immediately post- vs. 4 min 
post-exercise, respectively. Similarly, group mean DLNO 
was 237 ± 53 vs. 239 ± 51 ml/min/mmHg immediately 
post- vs. 4 min post-exercise, respectively. Thus, it appears 
that there was very little, if any, recovery in our measures of 
DLCO and DLNO during the time taken between exercise 
termination and the completion of our post-exercise assess-
ment of lung diffusion capacity.
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Conclusion
In conclusion, pulmonary capillary recruitment and disten-
sion in response to exercise at high altitude is largely lim-
ited in most well acclimatized humans, with only two of the 
seven participants in the present study appearing to maintain 
a reserve to expand the pulmonary vasculature in response 
to exercise in this environment, as evidenced by a substan-
tial increase in lung diffusing capacity for carbon monox-
ide and its component parts alveolar-capillary membrane 
conductance and pulmonary capillary blood volume. Addi-
tionally, the presence of such a reserve may be associated 
with better maintenance of aerobic exercise capacity at high 
altitude.
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